Home/Filings/4/0001140361-19-021634
4//SEC Filing

Avista Capital Managing Member IV, LLC 4

Accession 0001140361-19-021634

CIK 0001661181other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 4:17 PM ET

Size

62.2 KB

Accession

0001140361-19-021634

Insider Transaction Report

Form 4
Period: 2019-11-26
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Burgstahler David F
DirectorPresident and CEO10% Owner
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Dean Thompson
DirectorExecutive Chairman10% Owner
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Transactions
  • Purchase

    Class A common stock

    2019-11-26$5.00/sh+6,000,000$30,000,00024,975,165 total(indirect: See Notes)
Footnotes (5)
  • [F1]This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore" and together with ACP Onshore, the "Avista Funds"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.
  • [F2]Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019.
  • [F3]Represents the public offering price of $5.00 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 19, 2019, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 22, 2019 and filed as Exhibit 10.1 thereto.
  • [F4]Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.
  • [F5]Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Issuer

Organogenesis Holdings Inc.

CIK 0001661181

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001761175

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:17 PM ET
Size
62.2 KB